Trial · NCT01244763
Results by group1,062
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 1,062
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number (%) of Participants With an Hb Response by Week 17 | Cohort A: Roxadustat Tiered, Weight Based Dosing TIW | 19 | Participants | ||
| Number (%) of Participants With an Hb Response by Week 17 | Cohort B: Roxadustat Tiered, Weight Based Dosing TIW Then BIW | 24 | Participants | ||
| Number (%) of Participants With an Hb Response by Week 17 | Cohort C: Roxadustat at 50 mg TIW | 21 | Participants | ||
| Number (%) of Participants With an Hb Response by Week 17 | Cohort D: Roxadustat at 100 mg TIW | 23 | Participants | ||
| Number (%) of Participants With an Hb Response by Week 17 | Cohort E: Roxadustat Tiered, Weight Based Dosing BIW Then QW | 23 | Participants | ||
| Number (%) of Participants With an Hb Response by Week 17 | Cohort F: Roxadustat at 70 mg BIW Then QW | 21 | Participants | ||
| Number (%) of Participants With an Hb Response by Weeks 5, 9, 13, 17, 21, and 25 | Cohort A: Roxadustat Tiered, Weight Based Dosing TIW | Week 5 | 15 | Participants | |
| Number (%) of Participants With an Hb Response by Weeks 5, 9, 13, 17, 21, and 25 | Cohort B: Roxadustat Tiered, Weight Based Dosing TIW Then BIW | Week 5 | 14 | Participants | |
| Number (%) of Participants With an Hb Response by Weeks 5, 9, 13, 17, 21, and 25 | Cohort C: Roxadustat at 50 mg TIW | Week 5 | 3 | Participants | |
| Number (%) of Participants With an Hb Response by Weeks 5, 9, 13, 17, 21, and 25 | Cohort D: Roxadustat at 100 mg TIW | Week 5 | 13 | Participants | |
| Number (%) of Participants With an Hb Response by Weeks 5, 9, 13, 17, 21, and 25 | Cohort E: Roxadustat Tiered, Weight Based Dosing BIW Then QW | Week 5 | 9 | Participants | |
| Number (%) of Participants With an Hb Response by Weeks 5, 9, 13, 17, 21, and 25 | Cohort F: Roxadustat at 70 mg BIW Then QW | Week 5 | 9 | Participants | |
| Number (%) of Participants With an Hb Response by Weeks 5, 9, 13, 17, 21, and 25 | Cohort A: Roxadustat Tiered, Weight Based Dosing TIW | Week 9 | 18 | Participants | |
| Number (%) of Participants With an Hb Response by Weeks 5, 9, 13, 17, 21, and 25 | Cohort B: Roxadustat Tiered, Weight Based Dosing TIW Then BIW | Week 9 | 21 | Participants | |
| Number (%) of Participants With an Hb Response by Weeks 5, 9, 13, 17, 21, and 25 | Cohort C: Roxadustat at 50 mg TIW | Week 9 | 12 | Participants | |
| Number (%) of Participants With an Hb Response by Weeks 5, 9, 13, 17, 21, and 25 | Cohort D: Roxadustat at 100 mg TIW | Week 9 | 20 | Participants | |
| Number (%) of Participants With an Hb Response by Weeks 5, 9, 13, 17, 21, and 25 | Cohort E: Roxadustat Tiered, Weight Based Dosing BIW Then QW | Week 9 | 18 | Participants | |
| Number (%) of Participants With an Hb Response by Weeks 5, 9, 13, 17, 21, and 25 | Cohort F: Roxadustat at 70 mg BIW Then QW | Week 9 | 13 | Participants | |
| Number (%) of Participants With an Hb Response by Weeks 5, 9, 13, 17, 21, and 25 | Cohort A: Roxadustat Tiered, Weight Based Dosing TIW | Week 13 | 18 | Participants | |
| Number (%) of Participants With an Hb Response by Weeks 5, 9, 13, 17, 21, and 25 | Cohort B: Roxadustat Tiered, Weight Based Dosing TIW Then BIW | Week 13 | 23 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01244763/results